Anna Gruszka
22 works · 350 citations · h-index 11
Top works
- Potential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case report.
- The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the “clinically non-functioning” pituitary adenomas in vitro
- Angiotensins II and IV stimulate the rat adrenocortical cell proliferation acting via different receptors.
- Regulation of Growth Hormone and Prolactin Gene Expression and Secretion by Chimeric Somatostatin-Dopamine Molecules
- Proliferating cell nuclear antigen (PCNA) expression in pituitary adenomas: relationship to the endocrine phenotype of adenoma.
- Anti-tumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: anti-proliferative and pro-apoptotic effects.
- Diminished Pancreatic β-Cell Mass in Securin-Null Mice Is Caused by β-Cell Apoptosis and Senescence
- Rosiglitazone, PPAR-gamma receptor ligand, decreases the viability of rat prolactin-secreting pituitary tumor cells in vitro.
- Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with pituitary adenomas
- Melatonin inhibits growth of diethylstilbestrol‐induced prolactin‐secreting pituitary tumor in vitro: possible involvement of nuclear RZR/ROR receptors
- The effect of octreotide and bromocriptine on expression of a pro-apoptotic Bax protein in rat prolactinoma.
- The Antiproliferative Effects of Melatonin on Experimental Pituitary and Colonic Tumors
- Somatostatin analogs and chimeric somatostatin–dopamine molecules differentially regulate human growth hormone and prolactin gene expression and secretion in vitro
- Chromogranin A in pituitary adenomas: immunohistochemical detection and plasma concentrations.
- New Insight into the Mechanisms of the Anti-hyperglycemic Action of Metformin
- Long-term treatment with octreotide in a patient with malignant pheochromocytoma: impact on survival and time to tumor progression
- Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
- Serum alpha-subunit elevation after TRH administration: a valuable test in presurgical diagnosis of gonadotropinoma?
- Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation
- A patient with TSH-secreting pituitary macroadenoma, after previous thyroid ablation, successfully treated with long-acting octreotide formulation (octreotide-LAR) and transsphenoidal surgery